We know per prior updates what hasn't been done and there hasn't been any further communications that those unresolved items are now complete. By all appearances MK is likely to submit an IDE application soon to pump an offering during the consideration period and will likely at best receive a conditional approval, aka more FDA meetings before human trials.
News 
Market Data 
Discover 
